Results 251 to 260 of about 10,050,443 (381)

MmisAT and MmisP: an efficient and accurate suite of variant analysis toolkit for primary mitochondrial diseases. [PDF]

Hum Genomics, 2023
Huang S, Wu Z, Wang T, Yu R, Song Z, Wang H.   +5 more
europepmc   +1 more source

Symposium S12: Oxidative Stress and Mitochondrial Factors in Parkinson's Disease, Alzheimer's Disease and Amyotrophic Lateral Sclerosis

, 2000

openalex   +2 more sources

Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease [PDF]

, 2001
Aleksandra Muratovska, Robert N. Lightowlers, Robert W. Taylor, Douglass M. Turnbull, Robin A.J. Smith, Matthew C. J. Wilce, Stephen W. Martin, Michael P. Murphy   +7 more
openalex   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

Advanced Functional Materials, EarlyView.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth, Neal I. Callaghan, Locke Davenport Huyer   +2 more
wiley   +1 more source

Generation of an induced pluripotent stem cell (iPSC) line (INNDSUi008-A) from a patient with Spinocerebellar Ataxia Type 3

Stem Cell Research
Abnormal trinucleotide CAG repeat expansions in exon 10 of the ataxin-3 (ATXN3) gene has been identified as the cause of Spinocerebellar Ataxia Type 3 (SCA3).
Bo Li, Yingxin Wang, Yitong Yang, Didi Shan, Jianing Li, Hongxu Wang, Xiaohan Sun, Zexin Zhan, Xinbo Ji, Yao Tang, Yichang Jiao, Bo Kong, Bo Gao, Ping Sun, Fuchen Liu, Yu Wang   +15 more
doaj  

Protein Nitration in Patients with Mitochondrial Diseases. [PDF]

Antioxidants (Basel)
Livramento JB, Rodrigues GS, Faber J, de Souza Filho LA, Moura FV, Barros CDS, Pinto WBVR, Schmidt B, Oliveira ASB, Kiyomoto BH, Tengan CH.   +10 more
europepmc   +1 more source

Current advances in gene therapy of mitochondrial diseases. [PDF]

J Transl Med, 2022
Soldatov VO, Kubekina MV, Skorkina MY, Belykh AE, Egorova TV, Korokin MV, Pokrovskiy MV, Deykin AV, Angelova PR.   +8 more
europepmc   +1 more source

Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John, Caitlyn Dang, Nidhi Reddy, Calvin Chao, Karen J. Ho, Bin Jiang   +5 more
wiley   +1 more source

Therapeutic Approach to Epilepsy in Patients with Mitochondrial Diseases. [PDF]

Yonsei Med J
Na JH, Lee YM.
europepmc   +1 more source

Correction: Current advances in gene therapy of mitochondrial diseases. [PDF]

J Transl Med, 2023
Soldatov VO, Kubekina MV, Skorkina MY, Belykh AE, Egorova TV, Korokin MV, Pokrovskiy MV, Deykin AV, Angelova PR.   +8 more
europepmc   +1 more source